source
- Eli Lilly stops disclosing Phase 1 pipeline, prompting mixed reactionsEli Lilly announced that it will no longer publicly share details of its Phase 1 drug candidates. The policy shift comes as the company’s GLP-1 product continues to generate the highest sales among…
- Roche receives expanded FDA clearance for HER2 diagnostic tests linked to Jazz’s Ziihera cancer drugRoche announced that the U.S. Food and Drug Administration has broadened the clearance for two of its HER2 diagnostic assays, allowing their use in metastatic gastroesophageal adenocarcinoma. The…